Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Aufsätze"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=9
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=9
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=9
PubPharm (60.420)
81
A Study of Atezolizumab to investigate long term safety and efficacy in patients with locally advanced or metastatic non small cell lung cancer (NSCLC) : A PHASE III/IV, SINGLE ARM, MULTICENTER STUDY OF ATEZOLIZUMAB (TECENTRIQ) TO INVESTIGATE LONG-TERM SAFETY AND EFFICACY IN PREVIOUSLY-TREATED PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (TAIL)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
82
A Phase 3 study of an Investigational Drug, Lumasiran (ALN-GO1) in patients with advanced primary hyperoxaluria Type 1 : ILLUMINATE-C: A Single Arm Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1 (PH1)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
83
Olaparib in gBRCA Mutated Pancreatic Cancer whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy : A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Maintenance Olaparib Monotherapy in Patients with gBRCA Mutated Metastatic Pancreatic Cancer whose Disease Has Not Progressed on First Line Platinum Based Chemotherapy - POLO
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
84
A modular multi-Basket trial to improve personalized medicine in cancer patients : Basket of Baskets: A Modular, Open-label, Phase II, Multicentre Study To Evaluate Targeted Agents in Molecularly Selected Populations With Advanced Solid Tumors.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
85
Study to evaluate the efficacy and safety of Durvalumab (MEDI4736) in combination with intravesical BCG for the treatment of patients diagnosed with early stage bladder cancer (non-muscle invasive) compared to the standard therapy of intravesical BCG alone. : A Phase III Randomized, Open-Label, Multi-Center, Global Study of Durvalumab and Bacillus Calmette-Guerin (BCG) Administered as Combination Therapy Versus BCG Alone in High-Risk, BCG Naïve Non Muscle Invasive Bladder Cancer Patients (POTOMAC) - POTOMAC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
86
Tirzepatide versus placebo in NASH : A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparingthe Efficacy and Safety of Tirzepatide versus Placebo in Patients withNonalcoholic Steatohepatitis (NASH) - SYNERGY-NASH
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
87
Durvalumab Long-Term Safety and Efficacy Study : An Open-Label, Multi-Center, Global Study to Evaluate Long Term Safety and Efficacy in Patients Who are Receiving or Who Previously Received Durvalumab in Other Protocols (WAVE) - WAVE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
88
Phase 2 Study in 1L HNSCC of IT MK-1454 / MK-3475 IV vs MK-3475 IV : A Phase 2 Study in First Line Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma to Evaluate Intratumoral MK-1454 in Combination with IV Pembrolizumab vs IV Pembrolizumab Monotherapy - Phase 2 Study in 1L HNSCC of IT MK-1454 / MK-3475 IV vs MK-3475 IV
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
89
SERENA-2: A Randomised Comparative Phase 2 Study of AZD9833 versus Fulvestrant in Women with Advanced ER-Positive HER2-Negative Breast Cancer : SERENA-2: A Randomised, Open-Label, Parallel-Group, Multicentre Phase 2 Study Comparing the Efficacy and Safety of Oral AZD9833 versus Fulvestrant in Women with Advanced ER-Positive HER2-Negative Breast Cancer - SERENA-2
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
90
A Study to Evaluate SHR-1210 in Combination With Apatinib (Rivoceranib) as First-Line Therapy in Patients With Advanced HCC : A Randomized, Open-Label, International, Multi-Center, Phase 3 Clinical Study of PD-1 Antibody SHR-1210 Plus Apatinib (Rivoceranib) Mesylate Versus Sorafenib as First-Line Therapy in Subjects with Advanced Hepatocellular Carcinoma (HCC) Who Have Not Previously Received Systemic Therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
[1]
« Vorheriger
4
5
6
7
8
9
10
11
12
13
14
Nächster »
[6042]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Medienart: Aufsätze
Medienart
Aufsätze
60.420
E-Artikel
60.420
E-Ressourcen
Zeitschriftentitel
60.420
WHO International Clinical Trials Registry Plat...
Thema
60.420
610
60.420
Recruitment Status: Authorised-recruitment may ...
60.420
Study Type: Interventional
23.556
Phase: Phase 3
15.068
Phase: Phase 2
4.508
Phase: Phase 4
3.278
Phase: Phase 1
152
Medical Condition: Multiple Myeloma MedDRA vers...
122
Medical Condition: Moderately to Severely Activ...
114
Medical Condition: Diabetes Mellitus, Type 2 Me...
88
Medical Condition: Atopic Dermatitis MedDRA ver...
86
Medical Condition: Ulcerative Colitis MedDRA ve...
86
Medical Condition: Ulcerative Colitis MedDRA ve...
84
Medical Condition: Cystic Fibrosis MedDRA versi...
76
Medical Condition: Asthma MedDRA version: 20.0L...
68
Medical Condition: Myelofibrosis MedDRA version...
66
Medical Condition: Mild cognitive impairment (M...
64
Medical Condition: Chronic Obstructive Pulmonar...
64
Medical Condition: Moderately to Severely Activ...
64
Medical Condition: Multiple myeloma MedDRA vers...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
35.522
2020-
24.898
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
56.722
Englisch
1.244
Unbestimmt
1.058
Französisch
794
Spanisch
162
Finnisch
124
Deutsch
70
Schwedisch
58
Niederländisch
58
Italienisch
44
Dänisch
26
Galizisch
12
Ungarisch
10
Norwegisch
8
Tschechisch
6
Latein
4
Isländisch
2
Estnisch
2
Frisian
2
Hausa
2
Indonesisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...